Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Oscar Health Inc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B), while Oscar Health Inc trades at $34.09 (market cap $10.59B). The key difference: Oscar Health Inc is far larger — about 2.1× Oruka Therapeutics Inc. Common Stock's market cap, and Oscar Health Inc is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Oscar Health Inc for 15 Days on average.
| ORKA | OSCR | |
|---|---|---|
Market Cap | $5.08B | $10.59B |
Volume | 685,276 | 5,280,571 |
Sector | Health | Health |
52-Week High | $113.08 | $34.32 |
52-Week Low | $26.19 | $10.85 |
Typical Hold Time | 0 Days | 15 Days |
Enterprise Value | $4.21B | $6.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
